Interpreting small treatment differences from quality of life data in cancer trials: an alternative measure of treatment benefit and effect size for the EORTC-QLQ-C30

BACKGROUND: The EORTC-QLQ-C30 is a widely used health related quality of life (HRQoL) questionnaire in lung cancer patients. Small HRQoL treatment effects are often reported as mean differences (MDs) between treatments, which are rarely justified or understood by patients and clinicians. An alternat...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Iftekhar, Bashir, Zahid, Forster, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647515/
https://www.ncbi.nlm.nih.gov/pubmed/26573600
http://dx.doi.org/10.1186/s12955-015-0374-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647515/
https://www.ncbi.nlm.nih.gov/pubmed/26573600
http://dx.doi.org/10.1186/s12955-015-0374-6

Ejemplares similares